REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 3 filers reported holding REGENXBIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $521 | +9.2% | 29 | 0.0% | 0.00% | – |
Q3 2023 | $477 | -56.6% | 29 | -47.3% | 0.00% | – |
Q2 2023 | $1,099 | +109.7% | 55 | +89.7% | 0.00% | – |
Q1 2023 | $524 | -20.4% | 29 | 0.0% | 0.00% | – |
Q4 2022 | $658 | -89.0% | 29 | -88.0% | 0.00% | -100.0% |
Q3 2022 | $6,000 | +200.0% | 242 | +272.3% | 0.00% | +100.0% |
Q1 2022 | $2,000 | 0.0% | 65 | +132.1% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 28 | -24.3% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 37 | +19.4% | 0.00% | -100.0% |
Q3 2018 | $2,000 | – | 31 | +244.4% | 0.00% | – |
Q2 2018 | $0 | – | 9 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |